This study aimed to compare the effectiveness of preoperative PECS I block and intraoperative local anesthetic infiltration in managing postoperative pain following breast augmentation surgery. The primary focus was to evaluate their impact on postoperative pain levels, perioperative remifentanil and postoperative opioid consumption and opioid-related side effects during the early recovery period.
Who can participate
Age range18 Years – 59 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Female participants aged 18 to 59 years.
* ASA (American Society of Anesthesiologists) physical status I or II.
* Scheduled for primary breast augmentation surgery using a dual-plane or submuscular approach.
* Planned to receive silicone implants of identical volume and shape for both breasts.
* Able to provide written informed consent.
* Willing and able to comply with study procedures and follow-up assessments.
Exclusion Criteria:
* Planned subglandular or subfascial breast augmentation.
* Undergoing revision breast surgery.
* History of breast disease, previous breast or axillary surgery, or breast cancer.
* Preoperative breast pain or chronic pain syndromes (e.g., fibromyalgia, chronic headaches, back pain, complex regional pain syndrome, neuropathic pain, osteoarthritis, or radicular pain).
* BIRADS score \> 3 based on imaging (ultrasound/mammography) within the past year.
* Allergy to medications used in the study (e.g., bupivacaine, propofol, fentanyl, sevoflurane, cefazolin, paracetamol, ondansetron, tramadol, or morphine HCl).
* Coagulopathy or bleeding disorders.
* Pregnant or at risk of pregnancy.
* Inability to provide informed consent or communication difficulties.
* Significant medical conditions that may interfere with the study outcomes.